118 related articles for article (PubMed ID: 19224516)
1. Radioimmunotherapy prevents local recurrence of colonic cancer in an experimental model.
de Jong GM; Boerman OC; Heskamp S; Aarts F; Bleichrodt RP; Hendriks T
Br J Surg; 2009 Mar; 96(3):314-21. PubMed ID: 19224516
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunotherapy is an effective adjuvant treatment after cytoreductive surgery of experimental colonic peritoneal carcinomatosis.
Koppe MJ; Hendriks T; Boerman OC; Oyen WJ; Bleichrodt RP
J Nucl Med; 2006 Nov; 47(11):1867-74. PubMed ID: 17079821
[TBL] [Abstract][Full Text] [Related]
3. The effects of adjuvant experimental radioimmunotherapy and hyperthermic intraperitoneal chemotherapy on intestinal and abdominal healing after cytoreductive surgery for peritoneal carcinomatosis in the rat.
Aarts F; Bleichrodt RP; de Man B; Lomme R; Boerman OC; Hendriks T
Ann Surg Oncol; 2008 Nov; 15(11):3299-307. PubMed ID: 18712445
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and therapeutic efficacy of (125/131)I-, (186)Re-, (88/90)Y-, or (177)Lu-labeled monoclonal antibody MN-14 to carcinoembryonic antigen in mice with small peritoneal metastases of colorectal origin.
Koppe MJ; Bleichrodt RP; Soede AC; Verhofstad AA; Goldenberg DM; Oyen WJ; Boerman OC
J Nucl Med; 2004 Jul; 45(7):1224-32. PubMed ID: 15235070
[TBL] [Abstract][Full Text] [Related]
5. Timing of adjuvant radioimmunotherapy after cytoreductive surgery in experimental peritoneal carcinomatosis of colorectal origin.
Aarts F; Koppe MJ; Hendriks T; van Eerd JE; Oyen WJ; Boerman OC; Bleichrodt RP
Ann Surg Oncol; 2007 Feb; 14(2):533-40. PubMed ID: 17122992
[TBL] [Abstract][Full Text] [Related]
6. A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Aarts F; Hendriks T; Boerman OC; Koppe MJ; Oyen WJ; Bleichrodt RP
Ann Surg Oncol; 2007 Nov; 14(11):3274-82. PubMed ID: 17653591
[TBL] [Abstract][Full Text] [Related]
7. Experimental study of radioimmunotherapy versus chemotherapy for colorectal cancer.
de Jong GM; Bleichrodt RP; Eek A; Oyen WJ; Boerman OC; Hendriks T
Br J Surg; 2011 Mar; 98(3):436-41. PubMed ID: 21254023
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant radioimmunotherapy improves survival of rats after resection of colorectal liver metastases.
de Jong GM; Hendriks T; Eek A; Oyen WJ; Nagtegaal ID; Bleichrodt RP; Boerman OC
Ann Surg; 2011 Feb; 253(2):336-41. PubMed ID: 21217519
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant 131I-anti-CEA-antibody radioimmunotherapy inhibits the development of experimental colonic carcinoma liver metastases.
Mahteme H; Lövqvist A; Graf W; Lundqvist H; Carlsson J; Sundin A
Anticancer Res; 1998; 18(2A):843-8. PubMed ID: 9615730
[TBL] [Abstract][Full Text] [Related]
10. Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells.
Li XF; Kinuya S; Yokoyama K; Koshida K; Mori H; Shiba K; Watanabe N; Shuke N; Michigishi T; Tonami N
Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1669-74. PubMed ID: 12458402
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein.
Buchsbaum DJ; Khazaeli MB; Axworthy DB; Schultz J; Chaudhuri TR; Zinn KR; Carpenter M; LoBuglio AF
Clin Cancer Res; 2005 Nov; 11(22):8180-5. PubMed ID: 16299250
[TBL] [Abstract][Full Text] [Related]
12. Adjuvant radioimmunotherapy after radiofrequency ablation of colorectal liver metastases in an experimental model.
de Jong G; Hendriks T; Franssen G; Oyen W; Boerman O; Bleichrodt R
Eur J Surg Oncol; 2011 Mar; 37(3):258-64. PubMed ID: 21208773
[TBL] [Abstract][Full Text] [Related]
13. Radioimmunotherapy improves survival of rats with microscopic liver metastases of colorectal origin.
de Jong GM; Hendriks T; Eek A; Oyen WJ; Heskamp S; Bleichrodt RP; Boerman OC
Ann Surg Oncol; 2009 Jul; 16(7):2065-73. PubMed ID: 19430843
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo characterization of 177Lu-huA33: a radioimmunoconjugate against colorectal cancer.
Almqvist Y; Steffen AC; Tolmachev V; Divgi CR; Sundin A
Nucl Med Biol; 2006 Nov; 33(8):991-8. PubMed ID: 17127172
[TBL] [Abstract][Full Text] [Related]
15. Anti-L1CAM radioimmunotherapy is more effective with the radiolanthanide terbium-161 compared to lutetium-177 in an ovarian cancer model.
Grünberg J; Lindenblatt D; Dorrer H; Cohrs S; Zhernosekov K; Köster U; Türler A; Fischer E; Schibli R
Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1907-15. PubMed ID: 24859811
[TBL] [Abstract][Full Text] [Related]
16. 5-FU uptake in peritoneal metastases after pretreatment with radioimmunotherapy or vasoconstriction: an autoradiographic study in the rat.
Mahteme H; Sundin A; Larsson B; Khamis H; Arow K; Graf W
Anticancer Res; 2005; 25(2A):917-22. PubMed ID: 15868928
[TBL] [Abstract][Full Text] [Related]
17. Optimizing lutetium 177-anti-carbonic anhydrase IX radioimmunotherapy in an intraperitoneal clear cell renal cell carcinoma xenograft model.
Muselaers CH; Oosterwijk E; Bos DL; Oyen WJ; Mulders PF; Boerman OC
Mol Imaging; 2014; 13():1-7. PubMed ID: 24824962
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy of carcinoma of colon with [131I]-labeled recombinant chimeric monoclonal antibodies to carcinoembryonic antigen.
Lu QJ; Bian GX; Chen YY; Zhang M; Guo SM; Wen LQ
Acta Pharmacol Sin; 2005 Oct; 26(10):1259-64. PubMed ID: 16174444
[TBL] [Abstract][Full Text] [Related]
19. Immuno-chemotherapy reduces recurrence of malignant pleural mesothelioma: an experimental setting.
Ampollini L; Soltermann A; Felley-Bosco E; Lardinois D; Arni S; Speck RF; Weder W; Opitz I
Eur J Cardiothorac Surg; 2009 Mar; 35(3):457-62. PubMed ID: 19162494
[TBL] [Abstract][Full Text] [Related]
20. Can antibody galactosylation be used to improve radioimmunotherapy of induced peritoneal carcinomatosis of colonic origin in the rat?
Aarts F; Hendriks T; Eek A; Oyen WJ; Bleichrodt RP; Boerman OC
Cancer Biother Radiopharm; 2009 Feb; 24(1):29-34. PubMed ID: 19243245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]